Table 4.

Cox survival analysis for homogeneous groups of female patients

Survival (mo), median quartilesnLog-rank PSurvival (mo), median quartilesnLog-rank P
UCSD patientsCytomyx patients
PTHrP positive    63 (20, 126)66<0.001    55 (31, 80)110.213
PTHrP negative    14 (6, 41)30    24 (20, 80)16
AdenocarcinomasSquamous carcinomas
PTHrP positive    66 (31, 126)460.045    46 (17, 95)260.025
PTHrP negative    23 (16, 92)16    16 (6, 30)21
Stage I + IIStage III + IV
PTHrP positive    69 (34, 116)480.030    25 (14, 95)290.001
PTHrP negative    27 (20, 97)27    8 (4, 20)19
SmokersNonsmokers
PTHrP positive    46 (14, 92)520.037    NR (107, NR)110.004
PTHrP negative    14 (6, 41)25    20 (3, NR)8
Age ≥ 67 yAge < 67 y
PTHrP positive    34 (19, 71)320.005    71 (34, 176)450.066
PTHrP negative    16 (7, 23)28    41 (14, 94)18
Age < 56 y
PTHrP positive    71 (38, 176)230.024
PTHrP negative    20 (14, 92)8
  • NOTE: Log-rank P is for the comparison between PTHrP-negative and PTHrP-positive patients. There were only eight female patients with large cell carcinoma.

    Abbreviation: NR, not reached.